About us
Non-toxic silver, supported by centuries of empirical evidence, deserves to reclaim its position alongside Aspirin as either a grandfathered medication or as the subject of an NIH-funded clinical trial. This opportunity was lost due to FDA censorship that commenced in 1999. It is essential that the NIH prioritize the interests of citizens over those of big pharmaceutical companies.
